文献速递胸部CT

COVID-19患者胸部CT评分:与疾病严重程度及短期预后的相关性

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis.
PubMed 文献 · Eur Radiol · 2020-07-04

单中心回顾性纳入2020年3月6日至22日130例有症状SARS-CoV-2患者,基于肺叶受累范围的半定量CT评分(0-25分)与临床分期、实验室指标相关;CT评分≥18与死亡风险升高相关,单因素HR 8.33、多因素HR 3.74。

要点

  • CT评分≥18与短期死亡风险升高相关(多因素HR 3.74,95%CI 1.10-12.77)。
  • CT评分在危重及重型患者中高于轻型,晚期(>7天)高于早期(≤7天),均p<0.0001。
  • CT评分与CRP(r=0.6204)及D-二聚体(r=0.6625)水平显著相关。

关键影像表现/征象

  • 早期(症状出现≤7天)以磨玻璃影为主,晚期(>7天)以铺路石征、实变和纤维化为特征。
  • CT评分在危重和重型患者中显著高于轻型(p<0.0001),晚期患者显著高于早期(p<0.0001)。

诊断标准与关键数值

  • 半定量CT评分按肺叶受累范围计分:0分=0%,1分=<5%,2分=5-25%,3分=26-50%,4分=51-75%,5分=>75%,单叶范围0-5分,全局总分0-25分。
  • CT评分≥18与死亡风险升高相关,单因素分析HR 8.33(95%CI 3.19-21.73,p<0.0001),多因素分析HR 3.74(95%CI 1.10-12.77,p=0.0348)。

临床应用与阅片要点

  • 作者认为CT评分与实验室指标及疾病严重程度高度相关,可能有助于加快有症状病例的诊断流程。
  • 多因素分析显示CT肺实质评估可能更准确反映短期结局,提供解剖损伤的直接可视化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To correlate a CT-based semi-quantitative score of pulmonary involvement in COVID-19 pneumonia with clinical staging of disease and laboratory findings. We also aimed to investigate whether CT findings may be predictive of patients' outcome.

METHODS: From March 6 to March 22, 2020, 130 symptomatic SARS-CoV-2 patients were enrolled for this single-center analysis and chest CT examinations were retrospectively evaluated. A semi-quantitative CT score was calculated based on the extent of lobar involvement (0:0%; 1, < 5%; 2:5-25%; 3:26-50%; 4:51-75%; 5, > 75%; range 0-5; global score 0-25). Data were matched with clinical stages and laboratory findings. Survival curves and univariate and multivariate analyses were performed to evaluate the role of CT score as a predictor of patients' outcome.

RESULTS: Ground glass opacities were predominant in early-phase (≤ 7 days since symptoms' onset), while crazy-paving pattern, consolidation, and fibrosis characterized late-phase disease (> 7 days). CT score was significantly higher in critical and severe than in mild stage (p < 0.0001), and among late-phase than early-phase patients (p < 0.0001). CT score was significantly correlated with CRP (p < 0.0001, r = 0.6204) and D-dimer (p < 0.0001, r = 0.6625) levels. A CT score of ≥ 18 was associated with an increased mortality risk and was found to be predictive of death both in univariate (HR, 8.33; 95% CI, 3.19-21.73; p < 0.0001) and multivariate analysis (HR, 3.74; 95% CI, 1.10-12.77; p = 0.0348).

CONCLUSIONS: Our preliminary data suggest the potential role of CT score for predicting the outcome of SARS-CoV-2 patients. CT score is highly correlated with laboratory findings and disease severity and might be beneficial to speed-up diagnostic workflow in symptomatic cases.

KEY POINTS: • CT score is positively correlated with age, inflammatory biomarkers, severity of clinical categories, and disease phases. • A CT score ≥ 18 has shown to be highly predictive of patient's mortality in short-term follow-up. • Our multivariate analysis demonstrated that CT parenchymal assessment may more accurately reflect short-term outcome, providing a direct visualization of anatomic injury compared with non-specific inflammatory biomarkers.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020. PMID: 32623505. doi:10.1007/s00330-020-07033-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。